MDT Q3 2026 Earnings — Medtronic plc Revenue & Financial Results | Market Cap Arena

MDTMedtronic plc

$116B

Q3 2026 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$9.0B+8.8% YoY

Gross Profit

$5.9B64.9% margin

Operating Income

$1.8B19.7% margin

Net Income

$1.1B12.7% margin

EPS (Diluted)

$0.89

QoQ Revenue Growth

+0.6%

Cash Flow

Operating Cash Flow

$2.7B

Free Cash Flow

$2.3B

Stock-Based Comp.

$94M

Balance Sheet

Total Assets

$91.5B

Total Liabilities

$42.3B

Stockholders' Equity

$49.0B

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9.0B	$8.3B	+8.8%
Gross Profit	$5.9B	$5.5B	+6.1%
Operating Income	$1.8B	$1.6B	+7.7%
Net Income	$1.1B	$1.3B	-11.7%

Revenue Segments

Cardiac and Vascular Group

$3.5B38%

Neuroscience Group

$2.6B28%

Medical Surgical

$2.2B24%

Diabetes Group

$796M9%

Geographic Segments

UNITED STATES

$18.0B80%

Total Other Countries, Excluding United States and Ireland

$4.5B20%

IRELAND

$36M0%